Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Trummer, C; Theiler-Schwetz, V; Kollmann, M; Wölfler, M; Münzker, J; Pilz, S; Pieber, TR; Heijboer, AC; Obermayer-Pietsch, B; Lerchbaum, E.
Effects of vitamin D supplementation on metabolic and endocrine parameters in healthy premenopausal women: A randomized controlled trial.
Clin Nutr. 2020; 39(3):718-726
Doi: 10.1016/j.clnu.2019.03.007
Web of Science
PubMed
FullText
FullText_MUG
- Leading authors Med Uni Graz
- Trummer Christian
- Co-authors Med Uni Graz
- Kollmann Martina
- Lerchbaum Elisabeth
- Münzker Julia
- Obermayer-Pietsch Barbara
- Pieber Thomas
- Pilz Stefan
- Theiler-Schwetz Verena
- Wölfler Monika Martina
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Vitamin D supplementation may affect glycemic as well as hormonal regulation. Thus, the aim of the current study was to investigate whether vitamin D supplementation has any significant effects on metabolic and endocrine parameters in healthy premenopausal women. Primary outcome measure was the plasma glucose area under the curve (AUCgluc). The current study was a single-center, double-blind, randomized placebo-controlled trial that was conducted at the Medical University of Graz, Austria, between March 2013 and October 2017. One-hundred and fifty healthy premenopausal women with 25-hydroxyvitamin D [25(OH)D] concentrations <75 nmol/L once weekly received either 20,000 IU of cholecalciferol or placebo (2:1 ratio) over a total of 24 weeks. In total, 127 women [age 36.2 ± 8.7 years; BMI 25.3 ± 5.6 kg/m2; baseline 25(OH)D 55.8 ± 19.7 nmol/L] completed the study. Vitamin D supplementation had no significant effect on AUCgluc (mean treatment effect 11.70; p = 0.069), while it had a significant treatment effect on homeostatic model assessment-insulin resistance (HOMA-IR; mean treatment effect 0.31; p = 0.019) and quantitative insulin-sensitivity check index (QUICKI; mean treatment effect -0.019; p = 0.013). There was no significant effect on the remaining secondary outcome parameters. In this randomized-controlled trial in healthy premenopausal women, there was a significant treatment effect of vitamin D supplementation on HOMA-IR and QUICKI, while there was no significant treatment effect on AUCgluc. Copyright © 2019 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.
- Find related publications in this database (Keywords)
- Vitamin D supplementation
- RCT
- Insulin resistance
- Premenopausal